NuPulse Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Employees
  • 22

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $257K

  • Investors
  • 5

NuPulse General Information

Description

Developer of cardiovascular medical devices designed to treat patients with advanced chronic heart failure. The company's medical device is a minimally invasive, ambulatory counter pulsation device, which provides certain patients an alternative to chronic inotropes, enabling healthcare professionals to treat pediatric patients with cardiac dysfunction.

Contact Information

Website
www.nupulse.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 5734 Trinity Road
  • Suite 101
  • Raleigh, NC 27607
  • United States
+1 (800)
Primary Industry
Therapeutic Devices
Vertical(s)
Life Sciences
Corporate Office
  • 5734 Trinity Road
  • Suite 101
  • Raleigh, NC 27607
  • United States
+1 (800)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NuPulse Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Grant 01-Jul-2021 $257K Completed Generating Revenue
11. Debt - PPP 12-Apr-2020 Completed Generating Revenue
10. Later Stage VC (Series D) 24-Mar-2020 Completed Generating Revenue
9. Grant 01-Jul-2019 Completed Generating Revenue
8. Grant 16-Apr-2019 Completed Generating Revenue
7. Grant 01-Jan-2019 Completed Generating Revenue
6. Grant 26-Sep-2018 Completed Generating Revenue
5. Later Stage VC (Series C) 03-Jul-2018 Completed Generating Revenue
4. Later Stage VC (Series B) 30-Dec-2016 $15M $28.2M Completed Startup
3. Later Stage VC (Series A2) 02-Dec-2015 $6M $13.2M Completed Startup
To view NuPulse’s complete valuation and funding history, request access »

NuPulse Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series D
Series C
Series B
Series A2 33,493 $0.000100 6% $179.11 $179.11 1x $179.11 12.23%
Series A1 42,497 $0.000100 6% $150 $150 1x $150 15.52%
To view NuPulse’s complete cap table history, request access »

NuPulse Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of cardiovascular medical devices designed to treat patients with advanced chronic heart failure. The company'
Therapeutic Devices
Raleigh, NC
22 As of 2025

Austin, TX
 

Danvers, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

NuPulse Competitors (7)

One of NuPulse’s 7 competitors is Windmill Cardiovascular Systems, a Venture Capital-Backed company based in Austin, TX.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Windmill Cardiovascular Systems Venture Capital-Backed Austin, TX
Abiomed Corporate Backed or Acquired Danvers, MA
Medtronic Corporation Minneapolis, MN
Jarvik Heart Corporation New York, NY
Abbott Corporation Abbot Park, IL
You’re viewing 5 of 7 competitors. Get the full list »

NuPulse Patents

  • 131

    Total Documents Applications and Grants

  • Total Patents Families

  • 74

    Granted

  • 32

    Pending

  • Expiring in next 12 mo

NuPulse Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20250387614-A1 Systems, apparatuses, devices and methods of leak detection for pneumatic cardiac assist devices Pending 25-Apr-2024
WO-2025226749-A1 Systems, apparatuses, devices and methods of leak detection for pneumatic cardiac assist devices Pending 25-Apr-2024
EP-4491211-A1 Real-time detection of r-waves and methods therefor Pending 14-Jul-2023
JP-2025013282-A Real-time detection of r-waves and methods therefor Pending 14-Jul-2023
US-12752098-B2 Real-time detection of r-waves and methods therefor Active 14-Jul-2023 A61M60/161
To view NuPulse’s complete patent history, request access »

NuPulse Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NuPulse Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Institutes of Health Government
Nihon Kohden Corporation Minority
National Heart, Lung, and Blood Institute Government
Children's National Corporation
Broadview Ventures Venture Capital Minority
To view NuPulse’s complete investors history, request access »

Ready to get started?

Request a free trial

NuPulse FAQs

  • When was NuPulse founded?

    NuPulse was founded in 2010.

  • Where is NuPulse headquartered?

    NuPulse is headquartered in Raleigh, NC.

  • What is the size of NuPulse?

    NuPulse has 22 total employees.

  • What industry is NuPulse in?

    NuPulse’s primary industry is Therapeutic Devices.

  • Is NuPulse a private or public company?

    NuPulse is a Private company.

  • What is NuPulse’s current revenue?

    The current revenue for NuPulse is .

  • How much funding has NuPulse raised over time?

    NuPulse has raised $35.7M.

  • Who are NuPulse’s investors?

    National Institutes of Health, Nihon Kohden, National Heart, Lung, and Blood Institute, Children's National, and Broadview Ventures have invested in NuPulse.

  • Who are NuPulse’s competitors?

    Windmill Cardiovascular Systems, Abiomed, Medtronic, Jarvik Heart, and Abbott are some of the 7 competitors of NuPulse.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process